Kazuo Ogawa

Title: Kazuo Ogawa: Innovator in Heterocyclic Compounds

Introduction

Kazuo Ogawa is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. His work has implications for medical applications, especially in treating peptic ulcers.

Latest Patents

Kazuo Ogawa holds 1 patent related to heterocyclic compounds. The patent describes compounds of Formula I, where X and Y can be independently --NH--, --O--, or --S--, and Z may represent a pyrimidine, triazine, triazole, thiazole, or thiadiazole ring. The methods of preparation for these compounds are also detailed in the patent, highlighting their usefulness as antipeptic ulcer agents.

Career Highlights

Throughout his career, Ogawa has worked with prominent companies in the pharmaceutical industry. He has been associated with Otsuka Pharmaceutical Company, Limited and Ikeda Mohando Company, Ltd. His experience in these organizations has contributed to his expertise in the development of innovative compounds.

Collaborations

Kazuo Ogawa has collaborated with notable colleagues, including Tomoaki Fujinawa and Shunichi Shirai. These partnerships have likely enhanced his research and development efforts in the field of heterocyclic compounds.

Conclusion

Kazuo Ogawa's contributions to the field of chemistry, particularly through his patent on heterocyclic compounds, demonstrate his innovative spirit and dedication to improving medical treatments. His work continues to influence the pharmaceutical industry and offers potential benefits for patients suffering from peptic ulcers.